For Immediate Release
Electron Kebebew, MD, FACS Appointed Incoming Editor-in-Chief of Thyroid®
Contact: Kathryn Ryan
New Rochelle, NY, July 19, 2019—We are pleased to announce that Electron Kebebew, MD, FACS has been appointed the fifth Editor-in-Chief of Thyroid®, the Official Journal of the American Thyroid Association® (ATA®), published by Mary Ann Liebert, Inc., publishers. Dr. Kebebew succeeds Peter Andreas Kopp, MD who has provided exceptionally strong leadership for the journal over the last seven years. The latest Journal Impact Factor is 7.786.
Dr. Kebebew is the Chief of General Surgery and Harry A. Oberhelman Jr. and Mark L. Welton Professor at Stanford University. He is an internationally recognized expert in endocrine oncology and surgery.
“It is a great honor and privilege to be appointed incoming Editor-in-Chief of Thyroid,” said Kebebew. “I am looking forward to continuing, and upholding, the theme of excellence that Dr. Kopp has achieved with the journal and look forward to ensuring that Thyroid remains a foremost resource and influential publication in the field.”
Dr. Kebebew will work closely with Dr. Kopp through 2019, with a full transition to Editor-in-Chief in January 2020.
“The ATA is delighted that Dr. Electron Kebebew will be the next Editor-in-Chief of Thyroid. He will succeed Dr. Peter Kopp, who deserves considerable credit and our gratitude for steering the journal to its present prominence,” says American Thyroid Association President Elizabeth N. Pearce, M.D., M.Sc., Boston University, Boston, Massachusetts. “Electron is a globally recognized and respected leader in the field. His record of cutting-edge research in endocrine oncology and his plan for programmatic development in endocrine oncology at the Cancer Center at Stanford allows him to keep his finger on the pulse of many critical developments and advancements in the field. We are fortunate to have identified such a well-rounded scholar as the next Editor-in-Chief and have no doubt he will have a successful tenure and take the Journal to even greater heights.”
"We are very pleased to welcome Electron Kebebew as the fifth Editor-in-Chief of Thyroid, and look forward to working with him,” says Mary Ann Liebert, President of the company that bears her name.
About the Flagship Journal
Thyroid®, the Official Journal of the American Thyroid Association, is an authoritative peer-reviewed journal published monthly in print and online. The Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. A complete table of contents and free sample issue may be viewed online.
About the Society
The American Thyroid Association (ATA) is devoted to “Transforming thyroid care through clinical excellence, education, scientific discovery and advocacy in a collaborative community.” ATA is an international, individual professional membership organization for over 1,700 clinicians and researchers from 43 countries around the world, representing a broad diversity of medical disciplines. It also serves the public, patients, and their families through thyroid education and awareness efforts. Celebrating its 96th anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, Thyroid®, Clinical Thyroidology®, VideoEndocrinology, and Clinical Thyroidology for the Public; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators; support of online professional, public, and patient educational programs; and the development of guidelines for clinical management of thyroid disease. Find out more about ATA at www.thyroid.org.
About the Publisher
Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative medical and biomedical peer-reviewed journals, including Journal of Women’s Health, Diabetes Technology and Therapeutics, and Metabolic Syndrome and Related Disorders. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 90 journals, newsmagazines, and books is available at our website.